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evaluate the efficacy of iliac inflow repair and to identify clinical conditions that are associ-
ated with the need for runoff repair in concomitant iliac and superficial femoral artery
(SFA) occlusive disease.
Methods: Patients undergoing inflow repair for complicated flow-limiting iliac lesions with
diffuse SFA disease between 2007 and 2013 were retrospectively reviewed. Patients with poor
response to inflow repair underwent infrainguinal revascularization (IIR).
Results: The 29 ischemic limbs examined in this study represent 26 different patients (22
males; mean age, 77  8 years). Indications for inflow repair were Rutherford Classifications
III (31%), IV (31%), V (31%), and VI (7%). Severity of the complicated SFA disease was either TASC
(TransAtlantic Inter-Society Consensus) type C (14%) or type D (86%). Overall, freedom from IIR
was 90% after 30 days and 83% after 1 year. Patients having claudication, rest pain, and shallow
ischemic ulcers experienced the relief of symptoms, whereas patients with deep gangrene that
needed minor amputation required IIR more frequently (p < 0.01). Anatomical risk factors for
poor response to inflow repair were poor quality of the deep femoral artery (p < 0.01) and the
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nd/4.0/).1. Introduction
In cases of multilevel peripheral artery disease, such as
complicated superficial femoral artery (SFA) with iliac dis-
ease, surgeons may be hesitant to perform complete
revascularization because of operative stress or the pro-
longed operation time.1,2 In the past decade, endovascular
treatment (EVT) has become more widespread, and with
advanced technology, improved skills, and potentially
reduced invasiveness, complete revascularization has
become more feasible. New devices have improved the
initial success rate and patency during the early period;
however, the treatment of long-segment SFA disease has
scope for improvement, and its strategy has been a subject
of controversy.3e13 Traditionally, revascularization from an
iliac artery to the deep femoral artery without repair of the
SFA has been performed for iliac concomitant with SFA
disease.14e20 This “inflow repair” is a procedure that im-
proves collateral flow, via the deep femoral artery (DFA), to
the ischemic lower limb in cases of occlusion or severe
diffuse stenosis of the SFA. Inflow repair significantly im-
proves some clinical conditions and leads to safe revascu-
larization of the SFA. SFA revascularization is not always
justified in multifocal arterial disease, as some patients can
achieve symptom relief and limb salvage solely by inflow
repair.14,19,20 Furthermore, symptoms sometimes worsen if
stents placed in the SFA or the femoropopliteal bypass
grafts fail.21,22
The aim of this study was to evaluate the efficacy of
inflow repair and to identify clinical conditions that are
associated with poor outcomes, specifically infrainguinal
revascularization (IIR) in concomitant iliac and SFA occlu-
sive disease.2. Methods
Over a 6-year period (from February 2007 to December
2013), 56 limbs with concomitant iliac and SFA disease,
suffering from claudication, ischemic rest pain or tissue
loss, were referred to our hospital. Among these patients,
27 limbs required urgent minor amputation because of
tissue loss or infection and were expected to tolerate
complete revascularization; these patients underwent
IIR, in addition to iliac revascularization, as the primary
operation and were excluded from this analysis. Of the
remaining 26 patients, 29 limbs that underwent inflow
repair and considered staged runoff repair were included
in this analysis.
High-resolution computed tomography (CT) and pre- or
intraoperative digital subtraction angiography were per-
formed on all patients. Image analyses were focused on thekamatsu D, et al., Efficacy of ilia
an Journal of Surgery (2016), httlesion characteristics of the iliac artery and the SFA, and on
assessment of the quality of the DFA, popliteal artery, and
below-knee runoff vessels. Inclusion criteria for this anal-
ysis of iliac disease included flow-limiting stenosis (> 75%)
or occlusion, regardless of its length. The percent stenosis
was measured by comparing to the nearest normal diam-
eter. Concomitant SFA disease included in this analysis was
limited to TransAtlantic Inter-Society Consensus (TASC)23
type C or type D lesions.
The quality of the DFA was classified as good, fair, or
poor. The DFA was classified as poor when there was diffuse
> 50% stenosis or occlusion. The quality of the popliteal
artery was classified as good, fair or poor. The popliteal
artery was classified as poor when there was > 75% stenosis
or occlusion. The preoperative examination included ankle-
brachial index (ABI) and duplex imaging in all cases, and
skin perfusion pressure only in cases with critical limb
ischemia (CLI).
2.1. Operative procedures
Iliac revascularizations were routinely performed by EVT in
a hybrid operating room. An ipsilateral approach was used
for stenotic lesions, and a bidirectional approach was used
in cases with occlusive lesions. When the wire passed the
lesion, intravascular ultrasonography was routinely used to
check if the wire passed the true or false lumen, and to
assess the diameter. Direct stenting was usually performed,
but predilatation was used in cases that displayed an oc-
clusion with moderate or severe calcification. Stents were
placed in all iliac lesions. A common femoral artery (CFA)
endarterectomy was also performed in the same session
when there was a > 75% stenosis or occlusion in the CFA to
secure direct blood flow to the DFA, in addition to iliac
stenting. The CFA endarterectomy routinely closed without
patch. In a small number of cases, the CFA endarterectomy
risked injuring the artery when a hard, bulky calcification
reached near the adventitia. In such cases, bypass surgery
was conducted on the DFA. The decision to perform bypass
or CFA endarterectomy with iliac stent placement was at
the discretion of the surgeon. Inflow repair was deemed
technically successful if improved, direct blood flow to the
DFA was documented by final angiography.
2.2. Postoperative management
In patients with claudication, clinical success was defined
as the improved ability to walk, without disturbing daily
life. In patients with CLI, rest pain relief and healing of the
wound after debridement or minor amputation were
considered clinical success. An additional IIR was consid-
ered when patients wanted to further improve their abilityc inflow repair in patients with concomitant iliac and superficial
p://dx.doi.org/10.1016/j.asjsur.2016.07.004
Table 1 Baseline characteristics.
Age, y 77  8 (57e89)
Male sex 85 (22)
Risk factors
Hypertension 81 (21)
Diabetes mellitus 27 (7)
Dyslipidemia 41 (12)
CAD 19 (5)
CVD 31 (8)
OPD 23 (6)
CKD 19 (5)
Albumin, g/dL 3.4  0.5 (2.5e4.8)
BNP, pg/mL 105  130 (5.8e460)
Smoking history 79 (23)
Lower limb clinical status
Rutherford classification
3/4/5/6 31 (9)/31 (9)/31 (9)/7 (2)
ABI 0.3  0.3 (0e0.76)
CRP, mg/dL 2.27  2.72 (0.1e12.4)
Iliac lesion TASC A/B/C/D 7 (2)/31 (9)/38 (11)/24 (7)
CFA lesion 52 (15)
SFA lesion TASC C/D 14 (4) 86 (25)
DFA quality; poor 21 (6)
Popliteal quality; poor 52 (15)
Below-knee runoff 0/1/2/3 10 (3)/34 (10)/21
(6)/34 (10)
Data are presented as % (n) or mean  standard deviation
(range).
ABI Z ankle-brachial index; BNP Z brain natriuretic peptide;
CADZ coronary artery disease; CFAZ common femoral artery;
CKD Z chronic kidney disease; COPD Z chronic obstructive
pulmonary disease; CVD Z cerebrovascular disease;
DFA Z deep femoral artery; SFA, superficial femoral artery;
TASC Z TransAtlantic InterSociety Consensus.
Table 2 Initial procedures of inflow repair.
% (n)
Iliac revascularization alone 52 (15)
Iliac stents 45 (13)
Bypass 7 (2)
AxillareCFA 3 (1)
CFAeCFA crossover bypass 3 (1)
Iliac þ CFA revascularization 48 (14)
Hybrid operation 34 (10)
Iliac stents þ CFA endarterectomy 28 (8)
Contralateral iliac stents þ CFAeDFA
crossover bypass
7 (2)
Bypass 14 (4)
AxillareDFA bypass 14 (4)
CFA Z common femoral artery; DFA Z deep femoral artery.
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healing. Particularly in cases of CLI, additional infrainguinal
operations were performed without delay to prevent the
progression of gangrene. Routinely, patients with tissue loss
were hospitalized until granulation growth was acceptable
and wound contraction was achieved. Postoperatively, dual
antiplatelet therapy (100 mg aspirin plus 75 mg clopidogrel)
was administered and continued if adverse effects did not
develop. Postoperative assessment included clinical exam-
inations with ABI and duplex imaging in all patients and skin
perfusion pressure in cases of CLI within a week after the
initial procedure. An enhanced CT was conducted when the
ultrasonographic image was poor because of calcification.
ABI tests and ultrasonography were repeated every
3 months at our outpatient clinic. Patients with worsening
clinical symptoms underwent enhanced CT and/or
arteriography.
2.3. Study outcome measure
The primary endpoint was freedom from IIR after the
initial inflow repair; the secondary endpoints were pri-
mary patency of the revascularized inflow vessel and leg
amputation. Freedom from major adverse limb events
(MALEs), including amputation or any reintervention and
amputation-free survival (AFS), were also analyzed.
2.4. Statistical analysis
Continuous variables were expressed as the mean  stan-
dard deviation. Continuous variables were examined using
of unpaired t tests. Categorical variables were examined
using c2 tests. Survival curves were estimated using the
KaplaneMeier method and compared with the log-rank
test. A p value < 0.05 was considered statistically signifi-
cant. For statistical analysis, JMP pro 10 (SAS Institute Inc.,
Cary, NC, USA) was used.
The present study was carried out in accordance with
the Declaration of Helsinki, and all participants provided
written consent.
3. Results
3.1. Patients and procedures
The median patient age was 77 years (range, 57e89 years;
Table 1). The common risk factors were history of hyper-
tension (81%), smoking (79%), dyslipidemia (41%), cerebro-
vascular disease (31%), diabetes mellitus (27%), and
coronary artery disease (CAD; 19%). Indications for inflow
revascularization were claudication in nine procedures
(31%) and limb salvage in 20 procedures [69%; ischemic rest
pain in 9 (31%) and tissue loss in 11 (39%)]. According to the
TASC classification of iliac lesions, two limbs (7%), nine
limbs (31%), 11 limbs (38%), and seven limbs (24%) were in
classes A, B, C, and D, respectively. For the SFA lesions,
four limbs (14%) and 25 limbs (86%) were in classes C and D,
respectively. The CFA lesions were complicated in 52% of
limbs, and popliteal lesions were complicated in 52% of
limbs. Forty-four percent of the limbs had poor below-kneePlease cite this article in press as: Akamatsu D, et al., Efficacy of ilia
femoral artery occlusive disease, Asian Journal of Surgery (2016), httprunoff vessels ( 1 vessel). Regarding the quality of the
DFA, 21% of the limbs were of poor quality, that is, they
displayed diffuse stenosis or occlusion distal to the DFA.
Simple inflow repairs were performed by placing iliac
stents in 13 limbs (45%; Table 2). Hybrid operations were
performed in 10 limbs (34%). Eight limbs (28%) underwentc inflow repair in patients with concomitant iliac and superficial
://dx.doi.org/10.1016/j.asjsur.2016.07.004
Table 3 Univariate analysis: associations between
freedom from IIR, freedom from MALEs, AFS, and risk
factors.
Variables Univariate analysis (log-rank test,
p value)
Freedom
from IIR
Freedom
from
MALEs
AFS
Risk factors
Hypertension 0.48 0.79 0.32
Diabetes mellitus 0.59 0.45 0.57
CAD <0.01* <0.01* 0.01*
CVD 0.65 0.75 0.13
COPD 0.86 0.86 0.41
CKD 0.03* 0.03* 0.14
Albumin < 3
(g/dL)
0.19 0.44 0.2
BNP > 162
(pg/mL)
0.23 0.23 0.02*
Lower limb clinical status
Tissue loss <0.01* <0.01* <0.01*
ABI Z 0 0.28 0.27 0.27
CRP > 2.7
(mg/dL)
0.04* <0.01* 0.05
Arterial lesion characteristics
CFA lesion 0.18 0.18 0.88
DFA quality; poor <0.01* <0.01* 0.01*
Popliteal quality; poor 0.02* 0.1 0.6
Below-knee runoff  1 <0.01* <0.01* 0.16
* p < 0.05.
ABI Z ankle-brachial index; AFS Z amputation-free survival;
BNP Z brain natriuretic peptide; CAD Z coronary artery dis-
ease; CFA Z common femoral artery; CKD, chronic kidney dis-
ease; COPD Z chronic obstructive pulmonary disease;
CVD Z cerebrovascular disease; CRPZ C-reactive protein;
DFA Z deep femoral artery; IIRZ Infrainguinal revasculariza-
tion; MALEs Z major adverse limb events.
4 D. Akamatsu et al.
+ MODELCFA endarterectomy, in addition to having iliac stents
placed at the ipsilateral iliac lesion; two cases had stents
placed in the contralateral iliac lesion and a femorofemoral
crossover bypass with an ePTFE (expanded polytetra-
fluoroethylene) graft. Bypass surgery was conducted in six
limbs (21%), originating from the axillar artery in five limbs
(17%) and from the contralateral CFA in one limb (3%). In
four limbs (14%), out of those undergoing bypass surgeries,
the distal anastomosis sites were the DFA, bypassing the
CFA or the DFA orifice occlusion.
Surgical complications occurred in three cases. Compli-
cations included thrombus embolization in the DFA in two
patients and iliac perforation in one patient. There were no
perioperative deaths (< 30 days after surgery). The median
preoperative ABI for all patients was 0.3  0.3 [0.4  0.2
(0e0.8) in claudication patients and 0.2  0.2 (0e0.6) in CLI
patients] and improved to 0.6  0.1 [0.7  0.1 (0.6e0.8) in
claudication patients and 0.6 0.2 (0.4e0.8) in CLI patients].
3.2. Freedom from additional IIR
Within 6 months of the initial procedures, five limbs (17%)
required IIR. The median time between the initial proce-
dure and additional procedures was 28  38 days (range,
1e93 days). Two limbs underwent an above-knee femo-
ropopliteal bypass with an ePTFE graft, one limb underwent
a DFA-peroneal bypass with an autologous vein, and one
limb underwent EVT for an SFA occlusion. All limbs that
required IIR had gangrenous toes that needed minor
amputation, and inflow repair resulted in insufficient flow
improvement. Symptoms such as severe claudication, rest
pain, and shallow ischemic ulcers improved after inflow
repair and did not require IIR. Upon examining all patients,
freedom from IIR was 90% after 30 days and 83% after
1 year; freedom from IIR in patients with claudication/rest
pain was 100% after 30 days and 100% after 1 year; freedom
from IIR in patients with tissue loss was 73% after 30 days
and 53% after 1 year (Rutherford III plus IV vs. Rutherford V
plus VI, p < 0.01).
In a subanalysis of patients with tissue loss (Rutherford V
plus VI, nZ 11), limbs with deep gangrene that reached the
bone and required minor amputation (n Z 6) required
additional IIR more frequently than those with a shallow
ulcer (p Z 0.01).
Regarding other clinical backgrounds, patients with a
history of CAD (p < 0.01), a history of chronic kidney dis-
ease (CKD; pZ 0.03), C-reactive protein (CRP) > 2.7 mg/dL
(pZ 0.04), poor quality of the DFA (p < 0.01), poor quality
of the popliteal artery (p Z 0.02), and poor below-knee
runoff vessels (p < 0.01) were significantly more likely to
require additional IIR (Table 3, Figure 1).
3.3. Secondary endpoints
The overall primary patency rates for revascularized inflow
vessels at 1-, 3-, and 5-years were 100%, 95%, and 72%,
respectively. The mean follow-up period was
878  686 days (median, 630 days). At the 1-, 3-, and 5-year
follow-up visits, patency rates tended to be lower
(p Z 0.34) in patients with CLI (100%, 93%, and 65%,
respectively) than in patients with claudication (100%,Please cite this article in press as: Akamatsu D, et al., Efficacy of ilia
femoral artery occlusive disease, Asian Journal of Surgery (2016), htt100%, and 100%, respectively). Three failures occurred
13 months, 29 months, and 38 months after inflow repair; in
all of these, the initial symptom was rest pain, and none
required additional IIR. One limb had recurrent severe rest
pain and underwent an emergency thrombectomy of the
iliac stents and femoral revascularization with a prosthetic
graft to treat a common femoral lesion. One limb was
amputated because the patient became bedridden with
dementia and the limb was contractual during the follow-
up period. One limb was observed without revasculariza-
tion because the patient had minor ischemic symptoms.
The limb salvage rates at 1-, 3-, and 5-years after sur-
gery were 92%, 92%, and 79%, respectively, for all patients;
100%, 100%, and 100%, respectively, in patients with clau-
dication; and 89%, 89%, and 74%, respectively, in patients
with CLI (p Z 0.21). Four limbs were amputated during
follow-up; three were attributable to tissue loss and un-
derwent additional IIR. The limbs needing IIR were lower in
limb salvage (p Z 0.01).
MALEs, including major amputation and any type of
revascularization, were analyzed (Table 3). The freedom
from MALEs at the 1-, 3-, and 5-year follow-ups were 83%,c inflow repair in patients with concomitant iliac and superficial
p://dx.doi.org/10.1016/j.asjsur.2016.07.004
Figure 1 Freedom from infrainguinal revascularization (IIR)
after the initial inflow repair.
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and 100%, respectively, in patients with claudication; and
75%, 75%, and 56%, respectively, in patients with CLI
(p Z 0.09). History of CAD (p < 0.01), history of CKD
(p Z 0.03), CRP > 2.7 mg/dL (p < 0.01), tissue loss
(p < 0.01), poor below-knee runoff (1 vessel) (p <0.01),
and poor DFA quality (p < 0.01) were associated with the
incidence of MALEs. Survival rates at the 1-, 3-, and 5-year
follow-up, were 88%, 77%, and 64%, respectively, in all
patients; 100%, 100%, and 100%, respectively, in patients
with claudication; and 83%, 68%, and 54%, respectively, in
patients with CLI (pZ 0.11). The frequency rates of AFS at
1-, 3-, and 5-years after the initial procedure were 86%,
76%, and 54%, respectively. History of CAD (pZ 0.01), brain
natriuretic peptide (BNP) > 162 pg/mL (p Z 0.02), tissue
loss (p < 0.01), and poor quality of the DFA (pZ 0.01) were
associated with lower AFS rates (Table 3).
4. Discussion
The results of our study indicate the clinical conditions that
affect poor outcomes after inflow repair in concomitant
iliac and SFA occlusive disease. Although simultaneous
inflow and outflow repair is clinically effective,2 by the
1990s, inflow repair was widely used because of the high
mortality and morbidity associated with complete revas-
cularization using bypass surgery.1 Since then, advanced
endovascular techniques and technology have made
multilevel revascularization more feasible. Although EVT
and perioperative management have improved, complete
revascularization is not always justified because there is
always the possibility of nonessential runoff repair. In 1961,
Morris et al14 showed that it is generally sufficient to
reconstruct the iliofemoral segment with adequate results
in more than two-thirds of cases of multilevel arterial dis-
ease. Thereafter, the indications for and the efficacy of
inflow repair were discussed throughout the next two
decades.15e17 However, these issues have rarely been
addressed during the current endovascular era.Please cite this article in press as: Akamatsu D, et al., Efficacy of ilia
femoral artery occlusive disease, Asian Journal of Surgery (2016), httpDespite the small number of participants in our study,
inflow repair in patients with severe claudication resulted
in improved ABI and walking ability, enhancing the pa-
tients’ daily lives. As others have previously discussed,16e19
the important issues are patient selection and planning
treatment strategies in patients with CLI. In our early re-
sults, patients with rest pain or shallow foot ulcers expe-
rienced pain relief, experienced the healing of ulcers, and
averted major amputation without runoff repair. Although
some of these patients had a complicated DFA or more
distal runoff lesions, inflow repair reestablished blood flow
enough to achieve symptomatic relief. Patients with
gangrene that required minor amputation showed signifi-
cantly poor response to solo inflow repair. This probably
reflected the considerably higher perfusion needs for
wound healing and worsened distal runoff vessels in such
clinical situations. It would be better to perform outflow
revascularization along with inflow repair in those who
require minor amputation, if the patients’ conditions
permit, and staged outflow revascularization should be
considered in patients with rest pain or with a shallow foot
ulcer.
When considering the clinical success of inflow repair,
complicated arterial disease at sites other than the iliac or
the SFA is an essential point, especially in cases with CLI
requiring minor amputation. First, the quality of the DFA is
very important because it is the sole collateral source for
the lower extremity when the SFA is occluded.
In cases with complicated CFA disease, the best way to
treat the lesion is unclear. The percutaneous approach for
lesions in the CFA may be an alternative; however a hybrid
method combining iliac stents with open endarterectomy
would be better in terms of patency rate and
feasibility.24e27 In a few cases with CFA obstruction and
bulky calcification, bypass surgery anastomosing to the
patent DFA is an option because of the risks associated with
endarterectomy, specifically, irreparable arterial injury.
The anatomy of more distal runoff arteries was also
associated with clinical outcome after inflow repair;
although some previous reports supported this finding,16,18
others did not.19 A patent popliteal artery was an impor-
tant factor, probably because collateral vessels from the
DFA, such as the genicular arteries, merge at this point and
supply blood flow distally. Poor below-knee runoff was also
associated with the need for additional IIR. In the current
analysis, one or more patent crural arteries had a signifi-
cant predictive value for clinical outcome.
Higher levels of CRP, which reflect the extent of tissue
necrosis or infection, were associated with poor response to
inflow repair. Risk factors such as CAD or CKD were also
associated with poor response, probably because patients
with tissue loss were more afflicted with these disorders.
Although the current study included both endovascular
and a small number of bypass revascularizations, patency in
the current analysis was comparable to that of previous
studies25 that performed inflow repair in poor SFAs or runoff
vessels.20 In the present study, a nonsignificant tendency
toward a lower patency rate for inflow repair was observed
in patients with CLI compared to those with claudication.
There were several limitations in our study. First, the
present study is a retrospective observational study, with
potential, inherent biases associated with this method.c inflow repair in patients with concomitant iliac and superficial
://dx.doi.org/10.1016/j.asjsur.2016.07.004
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cording to their presentation, ambulatory status, and
medical condition. In addition, the number of cases was
small; thus, we could not perform multivariate analyses to
determine the factors that had the strongest effects on the
clinical success of inflow repairs.
In conclusion, we have identified the clinical conditions
affecting the success of inflow repair in patients with
multilevel arterial disease. IIR can be avoided even in cases
of CLI when those are not associated with gangrenous toes.
The appropriate use of inflow repair can limit nonessential
revascularizations.
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